744
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

The impact of PTSD clusters on cannabis use in a racially diverse trauma-exposed sample: An analysis from ecological momentary assessment

, PhD, , MA, , PhD, , PhD, , PhD & , PhD
Pages 532-542 | Received 19 Jun 2017, Accepted 16 Jan 2018, Published online: 14 Feb 2018

References

  • Kevorkian S, Bonn-Miller MO, Belendiuk K, Carney DM, Roberson-Nay R, Berenz EC. Associations among trauma, posttraumatic stress disorder, cannabis use, and cannabis use disorder in a nationally representative epidemiologic sample. Psychol Addict Behaviors. 2015;29(3):633–38. doi:10.1037/adb0000110.
  • Hasin DS, Kerridge BT, Saha TD, Huang B, Pickering R, Smith SM, Jung J, Zhang H, Grant BF. Prevalence and correlates of DSM-5 cannabis use disorder, 2012-2013: findings from the national epidemiologic survey on alcohol and related conditions-III. Am J Psychiatry. 2016;173(6):588. doi:10.1176/appi.ajp.2015.15070907.
  • Cougle JR, Bonn-Miller MO, Vujanovic AA, Zvolensky MJ, Hawkins KA. Posttraumatic stress disorder and cannabis use in a nationally representative sample. Psychol Addict Behaviors. 2011;25(3):554–58. doi:10.1037/a0023076.
  • Bonn-Miller MO, Harris AHS, Trafton JA. Prevalence of cannabis use disorder diagnoses among veterans in 2002, 2008, and 2009. Psychol Serv. 2012;9(4):404–16. doi:10.1037/a0027622.
  • Boden MT, Babson KA, Vujanovic AA, Short NA, Bonn‐Miller MO. Posttraumatic stress disorder and cannabis use characteristics among military veterans with cannabis dependence. Am J Addict. 2013;22(3):277–84. doi:10.1111/j.1521-0391.2012.12018.x.
  • Gentes EL, Schry AR, Hicks TA, Clancy CP, Collie CF, Kirby AC, Dennis MF, Hertzberg MA, Beckham JC, Calhoun PS. Prevalence and correlates of cannabis use in an outpatient VA posttraumatic stress disorder clinic. Psychol Addict Behav. 2016;30(3):415–21. doi:10.1037/adb0000154.
  • Grant S, Pedersen ER, Neighbors C. Associations of posttraumatic stress disorder symptoms with marijuana and synthetic cannabis use among young adult U.S. veterans: a pilot investigation. J Stud Alcohol Drugs. 2016;77(3):509–14. doi:10.15288/jsad.2016.77.509.
  • Baker TB, Piper ME, McCarthy DE, Majeskie MR, Fiore MC. Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev. 2004;111(1):33–51. doi:10.1037/0033-295x.111.1.33.
  • Conger JJ. Alcoholism: theory, problem and challenge II. Reinforcement theory and the dynamics of alcoholism. Q J Stud Alcohol. 1956;17(2):296–305.
  • Bonn-Miller MO, Vujanovic AA, Feldner MT, Bernstein A, Zvolensky MJ. Posttraumatic stress symptom severity predicts marijuana use coping motives among traumatic event-exposed marijuana users. J Trauma Stress. 2007;20(4):577–86. doi:10.1002/jts.20243.
  • Potter CM, Vujanovic AA, Marshall-Berenz EC, Bernstein A, Bonn-Miller MO. Posttraumatic stress and marijuana use coping motives: the mediating role of distress tolerance. J Anxiety Disord. 2011;25(3):437–43. doi:10.1016/j.janxdis.2010.11.007.
  • Earleywine M, Bolles JR. Marijuana, expectancies, and post-traumatic stress symptoms: a preliminary investigation. J Psychoactive Drugs. 2014;46(3):171–77. doi:10.1080/02791072.2014.920118.
  • Villagonzalo K-A, Dodd S, Ng F, Mihaly S, Langbein A, Berk M. The relationship between substance use and posttraumatic stress disorder in a methadone maintenance treatment program. Compr Psychiatry. 2011;52:562–66. doi:10.1016/j.comppsych.2010.10.001.
  • Bonn-Miller MO, Vujanovic AA, Drescher KD. Cannabis use among military veterans after residential treatment for posttraumatic stress disorder. Psychol Addict Behaviors. 2011;25(3):485–91. doi:10.1037/a0021945.
  • Bonn-Miller MO, Boden MT, Vujanovic AA, Drescher KD. Prospective investigation of the impact of cannabis use disorders on posttraumatic stress disorder symptoms among veterans in residential treatment. Psychol Trauma. 2013;5(2):193–200. doi:10.1037/a0026621.
  • Bremner JD, Southwick SM, Darnell A, Charney DS. Chronic PTSD in Vietnam combat veterans: course of illness and substance abuse. Am J Psychiatry. 1996;153(3):369–75. doi:10.1176/ajp.153.3.369.
  • Bonn-Miller MO, Babson KA, Vandrey R. Using cannabis to help you sleep: heightened frequency of medical cannabis use among those with PTSD. Drug Alcohol Depend. 2014;136:162–65. doi:10.1016/j.drugalcdep.2013.12.008.
  • Metrik J, Jackson K, Bassett SS, Zvolensky MJ, Seal K, Borsari B. The mediating roles of coping, sleep, and anxiety motives in cannabis use and problems among returning veterans with PTSD and MDD. Psychol Addict Behaviors. 2016;30(7):743–54. doi:10.1037/adb0000210.
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders, text revision. 4th ed. Washington, DC: American Psychiatric Association; 2000.
  • JAdS C, Zuardi AW, Garrido GEJ, Wichert-Ana L, Guarnieri R, Ferrari L, Azevedo-Marques PM, Hallak JEC, McGuire PK, Busatto GF. Effects of cannabidiol (CBD) on regional cerebral blood flow. Neuropsychopharmacology. 2004;29(2):417–26. doi:10.1038/sj.npp.1300340.
  • Manzanares J, Urigüen L, Rubio G, Palomo T. Role of endocannabinoid system in mental diseases. Neurotox Res. 2004;6(3):213–24. doi:10.1007/BF03033223.
  • Karniol IG, Shirakawa I, Kasinski N, Pfeferman A, Carlini EA. Cannabidiol interferes with the effects of Δ9-tetrahydrocannabinol in man. Eur J Pharmacol. 1974;28:172–77. doi:10.1016/0014-2999(74)90129-0.
  • Berrendero F, Maldonado R. Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol. Psychopharmacology. 2002;163(1):111–17. doi:10.1007/s00213-002-1144-9.
  • Cousens K, DiMascio A. (-)D9THC as an hypnotic: an experimental study of three dose levels. Psychopharmacologia. 1973;33(4):355–64. doi:10.1007/BF00437513.
  • Roitman P, Mechoulam R, Cooper-Kazaz R, Shalev A. Preliminary, open-label, pilot study of add-on oral Δ-tetrahydrocannabinol in chronic post-traumatic stress disorder. Clin Drug Investig. 2014;34(8):587–91. doi:10.1007/s40261-014-0212-3.
  • Jetly R, Heber A, Fraser G, Boisvert D. The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: a preliminary randomized, double-blind, placebo-controlled cross-over design study. Psychoneuroendocrinology. 2015;51:585–88. doi:10.1016/j.psyneuen.2014.11.002.
  • Neumeister A, Normandin MD, Pietrzak RH, Piomelli D, Zheng MQ, Gujarro-Anton A, Potenza MN, Bailey CR, Lin SF, Najafzadeh S, et al. Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. Mol Psychiatry. 2013;18(9):1034–40. doi:10.1038/mp.2013.61.
  • Shiffman S, Stone AA, Hufford MR. Ecological momentary assessment. Annu Rev Clin Psychol. 2008;4:1–32. doi:10.1146/annurev.clinpsy.3.022806.091415.
  • Buckner JD, Zvolensky MJ, Crosby RD, Wonderlich SA, Ecker AH, Richter AA. Antecedents and consequences of cannabis use among racially diverse cannabis users: an analysis from ecological momentary assessment. Drug Alcohol Depend. 2015;147:20–25. doi:10.1016/j.drugalcdep.2014.12.022.
  • Weathers FW, Litz BT, Herman DS, Huska JA, Keane TM. The PTSD checklist: reliability, validity, and diagnostic utility. Paper presented at: 9th Annual Meeting of the International Society for Traumatic Stress Studies; 1993 Oct; San Antonio, TX.
  • Brewin CR. Systematic review of screening instruments for adults at risk of PTSD. J Trauma Stress. 2005;18(1):53–62. doi:10.1002/jts.20007.
  • Cheng HL, Mallinckrodt B. Racial/ethnic discrimination, posttraumatic stress symptoms, and alcohol problems in a longitudinal study of Hispanic/Latino college students. J Couns Psychol. 2015;62(1):38–49. doi:10.1037/cou0000052.
  • Holland JM, Malott J, Currier JM. Meaning made of stress among veterans transitioning to college: examining unique associations with suicide risk and life-threatening behavior. Suicide Life-Threat Behav. 2014;44(2):218–31. doi:10.1111/sltb.12061.
  • Sobell LC, Sobell MB. Timeline followback user’s guide: a calendar method for assessing alcohol and drug use. Toronto: Addiction Research Foundation; 1996.
  • Fals-Stewart W, O’Farrell TJ, Freitas TT, McFarlin SK, Rutigliano P. The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J Consult Clin Psychol. 2000;68(1):134–44. doi:10.1037/0022-006X.68.1.134.
  • Wheeler L, Reis HT. Self-recording of everyday life events: origins, types, and uses. J Pers. 1991;59(3):339–54. doi:10.1111/1467-6494.ep9110141804.
  • Wolpe J. Psychotherapy by reciprocal inhibition. Cond Reflex. 1968;3(4):234–40.
  • Buckner JD, Crosby RD, Wonderlich SA, Schmidt NB. Social anxiety and cannabis use: an analysis from ecological momentary assessment. J Anxiety Disord. 2012;25(1):297–304. doi:10.1016/j.janxdis.2011.12.006.
  • Crosby RD, Wonderlich SA, Engel SG, Simonich H, Smyth J, Mitchell JE. Daily mood patterns and bulimic behaviors in the natural environment. Behav Res Ther. 2009;47(3):181–88. doi:10.1016/j.brat.2008.11.006.
  • Freedman MJ, Lester KM, McNamara C, Milby JB, Schumacher JE. Cell phones for ecological momentary assessment with cocaine-addicted homeless patients in treatment. J Subst Abuse Treat. 2006;30(2):105–11. doi:10.1016/j.jsat.2005.10.005.
  • Buckner JD, Zvolensky MJ, Ecker AH. Cannabis use during a voluntary quit attempt: an analysis from ecological momentary assessment. Drug Alcohol Depend. 2013;132(3):610–16. doi:10.1016/j.drugalcdep.2013.04.013.
  • Kreft I, De Leeuw J. Introducing multivlevel modeling. Thousand Oaks, CA: Sage Publications, Inc; 1998.
  • Hopper JW, Su Z, Looby AR, Ryan ET, Penetar DM, Palmer CM, Lukas SE. Incidence and patterns of polydrug use and craving for ecstasy in regular ecstasy users: an ecological momentary assessment study. Drug Alcohol Depend. 2006;85(3):221–35. doi:10.1016/j.drugalcdep.2006.04.012.
  • Kouri EM, Pope HG Jr. Abstinence symptoms during withdrawal from chronic marijuana use. Exp Clin Psychopharmacol. 2000;8(4):483–92. doi:10.1037/1064-1297.8.4.483.
  • Bolla KI, Lesage SR, Gamaldo CE, Neubauer DN, Funderburk FR, Cadet JL, David PM, Verdejo-Garcia A, Benbrook AR. Sleep disturbance in heavy marijuana users. Sleep. 2008;31(6):901–08. doi:10.1093/sleep/31.6.901.
  • Caldeira KM, Arria AM, O’Grady KE, Vincent KB, Wish ED. The occurrence of cannabis use disorders and other cannabis-related problems among first-year college students. Addict Behav. 2008;33(3):397–411. doi:10.1016/j.addbeh.2007.10.001.
  • Buckner JD, Carroll KM. Effect of anxiety on treatment presentation and outcome: results from the marijuana treatment project. Psychiatry Res. 2010;178(3):493–500. doi:10.1016/j.psychres.2009.10.010.
  • Bonn-Miller MO, Moos RH. Marijuana discontinuation, anxiety symptoms, and relapse to marijuana. Addict Behav. 2009;34(9):782–85. doi:10.1016/j.addbeh.2009.04.009.
  • Shrier LA, Walls C, Rhoads A, Blood EA. Individual and contextual predictors of severity of marijuana use events among young frequent users. Addict Behav. 2013;38(1):1448–56. doi:10.1016/j.addbeh.2012.05.026.
  • Gaher RM, Simons JS, Hahn AM, Hofman NL, Hansen J, Buchkoski J. An experience sampling study of PTSD and alcohol-related problems. Psychol Addict Behaviors. 2014;28(4):1013–25. doi:10.1037/a0037257.
  • Breslau N, Davis GC, Schultz LR. Posttraumatic stress disorder and the incidence of nicotine, alcohol, and other drug disorders in persons who have experienced trauma. Arch Gen Psychiatry. 2003;60(3):289–94. doi:10.1001/archpsyc.60.3.289.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.